Clinical Trial

Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma

Name: Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma — clinical trial record (NCT02497898)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to study the safety and efficacy of chemotherapy usage followed by CIK transfusion in refractory and/or chemoresistant lymphomas.

Trial Details

NCT Number	NCT02497898
Lead Sponsor	The First People's Hospital of Changzhou
Conditions	Lymphoma, Non-Hodgkin
Enrollment	1,000 participants
Start Date	2015-07
Primary Completion	2038-07 (estimated)
Study Completion	2040-07 (estimated)
Updated on ClinicalTrials.gov	2015-07-15